Trial Profile
A Prospective, Randomized, Open Label, Multicenter Trial of EC-MPS With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen for the Prevention of Acute Rejection Episodes in de Novo Renal Transplant Recipients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Ciclosporin; Corticosteroids
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Novartis
- 04 Nov 2011 New trial record